Xcout IntelSign inSubscribe

Pulmonx Corporation competitors & alternatives

LUNGMedical DevicesRedwood City, United States

The 12 closest competitors and alternatives to Pulmonx Corporation among medical devices companies — ranked by similarity to what Pulmonx Corporation actually does, not by market-cap band.

$76.2MMarket cap
296Employees
12Competitors listed

Subscribe to see Pulmonx Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Pulmonx Corporation

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.

Pulmonx Corporation at a glance

Pulmonx Corporation is a medical devices company headquartered in Redwood City, United States. It is publicly listed (LUNG) with a market capitalisation of $76.2M. Xcout tracks 26 named people at Pulmonx Corporation, including Glendon E. French (Chief Executive Officer, President & Director).

Pulmonx Corporation leadership

  • Glendon E. FrenchChief Executive Officer, President & Director
  • Glen FrenchPresident & Chief Executive Officer
  • Derrick SungChief Financial Officer & Chief Operating Officer
  • Derrick Sung, Ph.D.Chief Operating Officer & Chief Financial Officer
  • Geoffrey Beran RoseChief Commercial Officer
  • Beran RoseChief Commercial Officer

20 more named people on record for Pulmonx Corporation, with roles, board committees and tenure — see the full roster →

Pulmonx Corporation funding rounds before its IPO

Every round on record:

DateRoundAmountInvestors
DebtUndisclosed—

Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Pulmonx Corporation competitors

Ranked by semantic similarity — how close each company is to Pulmonx Corporation by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Varex Imaging CorporationVREX · Medical - DevicesSalt Lake City, United States
62% matchPublicAI 0/100 ▼Green 0/100 ▼

Medical - Devices

Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.

Market cap$777.2M
Employees2,450
AzurePython
Varex Imaging Corporation competitors & alternatives →
ESCALON MEDICAL CORPESMC · Medical DevicesWayne, United States
61% matchPublic

Similar medical devices company

Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.

Market cap$1.1M
Employees40
ESCALON MEDICAL CORP competitors & alternatives →
BRONCUS-B02216 · Medical DevicesUnited States
69% matchPublic

Similar medical devices company

Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Market cap$51M
Employees191
BRONCUS-B competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Pulmonx Corporation and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pulmonx Corporationand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →